1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Tourmaline Bio, Inc.

Tourmaline Bio, Inc.

TRML
Tourmaline Bio, Inc.US flagNASDAQ Global Select
47.98
USD
- -
- -
1.23BMarket Cap

Income Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Sales/Revenue/Turnover
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
- -
20
45
90
+ Selling, General & Admin
- -
2
13
23
+ Research & Development
- -
18
32
67
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
- -
-20
-45
-90
- Non-Operating (Income) Loss
- -
- -
-3
-17
+ Interest Expense, Net
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
-3
-17
Pretax Income
- -
-20
-42
-73
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-20
-42
-73
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-20
-42
-73
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
- -
-20
-42
-73
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-20
-42
-73
EBIT
- -
-20
-45
-90
EBITDA
- -
-20
-45
-90
EBITDA Margin (%)
- -
- -
- -
- -
EBITA
- -
-20
-45
-90
Gross Margin (%)
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
20
5
25
Basic EPS, GAAP
- -
-0.97
-8.87
-2.89
Basic EPS from Cont Ops
- -
-0.97
-8.87
-2.89
Diluted Weighted Avg Shares
- -
20
5
25
Diluted EPS, GAAP
- -
-0.97
-8.87
-2.89
Diluted EPS from Cont Ops
- -
-0.97
-8.87
-2.89

Balance Sheet (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Total Current Assets
- -
8
209
269
+ Cash, Cash Equivalents & STI
- -
8
203
258
+ Cash & Cash Equivalents
- -
8
141
31
+ ST Investments
- -
- -
62
228
+ Accounts & Notes Receiv
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
- -
- -
6
11
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
- -
1
1
40
+ Property, Plant & Equip, Net
- -
1
- -
- -
+ Property, Plant & Equip
- -
1
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
37
+ LT Investments
- -
- -
- -
37
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
3
+ Total Intangible Assets
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
1
3
Total Assets
- -
9
210
309
+ Payables & Accruals
- -
1
3
5
+ Accounts Payable
- -
- -
1
4
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
2
1
+ ST Debt
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
2
4
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
2
4
Total Current Liabilities
- -
1
5
9
+ LT Debt
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
+ Other LT Liabilities
- -
27
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
- -
27
- -
- -
Total Noncurrent Liabilities
- -
27
- -
- -
Total Liabilities
- -
29
5
9
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
267
435
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
267
435
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
- -
-20
-62
-135
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
- -
-20
205
300
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
- -
-20
205
300
Total Liabilities & Equity
- -
9
210
309
Shares Outstanding
20
20
20
26
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
- -
1
- -
- -
Net Debt
- -
-8
-141
-31
Net Debt to Equity
- -
41.85
-68.63
-10.17
Tangible Common Equity Ratio
-150.67
-216.88
97.5
97.1
Current Ratio
0.4
6.1
41.76
30.18
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
+ Net Income
- -
-20
-42
-73
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
- -
12
14
-1
+ Stock-Based Compensation
- -
- -
6
7
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
12
8
-8
+ Chg in Non-Cash Work Cap
- -
1
- -
-3
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-2
-5
+ Inc (Dec) in Accts Payable
- -
1
2
4
+ Inc (Dec) in Other
- -
- -
-1
-2
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
- -
-6
-28
-77
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-5
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
-5
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
70
161
+ Increase in Capital Stock
- -
- -
70
161
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
4
-194
+ Dec in LT Investment
- -
- -
20
172
+ Inc in LT Investment
- -
- -
-17
-366
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
- -
-5
4
-194
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
+ Repayments of Debt
- -
-1
- -
- -
+ Other Financing Activities
- -
20
86
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
- -
20
157
161
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
- -
8
132
-110
EBITDA
- -
-20
-45
-90
EBITDA Margin (%)
- -
- -
- -
- -
Free Cash Flow
- -
-12
-28
-77
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-7
-28
-77
Free Cash Flow per Basic Share
- -
-0.57
-5.93
-3.05
Price/Free Cash Flow
- -
-66.28
-4.43
-6.65
Cash Flow to Net Income
- -
0.33
0.67
1.06
Capital Expenditures
- -
-5
- -
- -